Clinical Thyroidology® for the Public

Volume 13

Clinical Thyroidology® for the Public summarizes selected research studies discussed in the previous month’s issue of Clinical Thyroidology, an official publication of the American Thyroid Association®.

Search Clinical Thyroidology® for the Public

 

Volume 13 2020

  • October is Thyroid Nodules Awareness Month

    In this issue Volume 13 Issue 10, the studies ask the following questions:

    1. Does COVID-19 infection affect the thyroid?
    2. Are there options besides anti-thyroid medications for treating Graves’ disease during pregnancy?
    3. Is the use of thyroid hormone increasing in the United States?
    4. Are women with a history of miscarriage or infertility have a high risk of hypothyroidism?
    5. Does increasing the levothyroxine dose affect mood in older hypothyroid patients?
    6. Is the rate of surgery decreasing in patients that had been undergoing active surveillance for papillary microcarcinoma?

  • September is Thyroid Cancer Awareness Month

    In this issue Volume 13 Issue 9, the studies ask the following questions:

    1. Are new chemotherapy drugs effective against anaplastic thyroid cancer?
    2. If you had a low risk papillary thyroid cancer, would you choose to monitor closely or to have surgery?
    3. How common is salivary gland damage after radioactive iodine therapy for thyroid cancer?
    4. Due positive thyroglobulin antibodies indicate a recurrence of thyroid cancer?
    5. Are there effective non-surgical options for the treatment of benign thyroid nodules?
    6. Is a fixed dose of radioactive iodine effective treatment for toxic multinodular goiters?

  • August is Thyroid & Pregnancy Awareness Month

    In this issue Volume 13 Issue 8, the studies ask the following questions:

    1. Do women with subclinical hypothyroidism during pregnancy continue to have hypothyroidism after delivery?
    2. Do thyroid problems during cancer immunotherapy treatment affect prognosis?
    3. Does levothyroxine return metabolism to normal in obese hypothyroid women?
    4. Is obesity a risk factor for thyroid cancer?
    5. Are aggressive papillary thyroid cancer subtypes increasing?
    6. Can thyroglobulin levels in thyroid cancer patient be followed after a lobectomy?

  • July is Graves' Disease Awareness Month

    In this issue Volume 13 Issue 7, the studies ask the following questions:

      1. What is the best treatment for Graves’ disease?
      2. Does changing brands of levothyroxine alter thyroid function tests?
      3. Does the heart beat stronger with thyroid hormone treatment in older patients with mild hypothyroidism?
      4. Does amiodarone therapy increase the risk of developing thyroid storm?
      5. What are patient preferences for surgery in low risk thyroid cancer?
      6. Does extension of thyroid cancer outside of the thyroid impact response to therapy?

  • June is Differentiated Thyroid Cancer Awareness Month

    In this issue Volume 13 Issue 6, the studies ask the following questions:

    1. Has the mortality rate for thyroid cancer changes in the past 30 years?
    2. Do patients with small papillary thyroid cancers need surgery?
    3. Can stimulated thyroglobulin levels predict prognosis in children with thyroid cancer?
    4. Is levothyroxine overtreatment during pregnancy harmful?
    5. Is subclinical hypothyroidism during pregnancy associated with pre-term delivery?
    6. Can thyroid surgery be done in an outpatient setting?/li>

  • May is International Thyroid Awareness Month

    In this issue Volume 13 Issue 5, the studies ask the following questions:

    1. Does financial and health insurance status affect clinical management and quality of life in patients with thyroid cancer?
    2. Does patient preference affect the intensity of thyroid cancer surveillance?
    3. Does selenium supplementation during pregnancy affect thyroid function?
    4. Does “block and replace” have a role in the management of Graves’ disease in children?
    5. Do the new cancer chemotherapy agents affect thyroid function?
    6. What is the best use of radioactive iodine in the management of thyroid cancer?

  • April is Hashimoto's Thyroiditis Awareness Month

    In this issue Volume 13 Issue 4, the studies ask the following questions:

    1. Is there a risk of cancer following radioactive iodine therapy for hyperthyroidism?
    2. Do steroids prevent thyroid eye disease after radioactive iodine?
    3. Does thyroid surgery cause depression?
    4. Does obesity cause thyroid cancer?
    5. Does extension of thyroid cancer outside of the thyroid
      affect prognosis?
    6. Does exposure to flame retardants during pregnancy
      cause thyroid problems?

  • March is Hypothyroidism Awareness Month

    In this issue Volume 13 Issue 3, the studies ask the following questions:

    1. Does treatment of hyperthyroidism cause obesity?
    2. Is treatment of subclinical hypothyroidism indicate in the elderly?
    3. Does iodine supplementation in populations that are iodine deficient cause an increase in thyrotoxicosis?
    4. Does the effect of surgery for low risk papillary thyroid cancer affect quality of life?
    5. Does BPA exposure affect thyroid hormone levels in pregnant women?
    6. Are children with Hashimoto’s thyroiditis or Graves’ disease at risk for developing autoimmune gastritis?

  • In this issue Volume 13 Issue 2, the studies ask the following questions:

    1. What is the risk of heart problems in patients with hypothyroidism?
    2. What is the risk of liver problems in patients with Graves’ disease treated with antithyroid drugs?
    3. Is there a risk assessment calculator for problems occurring after thyroid surgery?
    4. Does the unstimulated thyroglobulin level 6 weeks after surgery predict thyroid cancer recurrence?
    5. Do aggressive variants of papillary thyroid cancer affect survival?
    6. How does the new Afirma™ GSG test perform in indeterminate thyroid nodules?

  • In this issue Volume 13 Issue 1, the studies ask the following questions:

    1. What is the best dose of levothyroxine after thyroidectomy?
    2. Are there any negative health outcomes when the TSH is maintained in the normal range?
    3. Does treatment of Graves’ disease affect levels of TSH receptor antibodies?
    4. Is there an association between Graves’ disease and thyroid cancer?
    5. Are there markers to predict the spread of thyroid cancer to lymph nodes?
    6. Does the size of lymph nodes involved with cancer predict risk of recurrence of thyroid cancer?

Clinical Thyroidology® for the Public Past Issues

2014 – 2019

VOLUME 12

VOLUME 11

VOLUME 10

VOLUME 9

VOLUME 8

VOLUME 7

2011 – 2013

VOLUME 6

VOLUME 5

VOLUME 4

2008 – 2010

VOLUME 3

VOLUME 2

VOLUME 1

Editor
Alan P. Farwell, MD, FACE
Boston Medical Center
Boston University School of Medicine

Editorial Board
Jessie Block-Galaraza, MD, Albany, NY
Gary Bloom, New York, NY
Maria Brito, MF, New York, NY
Susana Ebner, MD, New York, NY
Alina Gavrila, MD, MMSC, Boston, MA
Melanie Goldfarb, MD, MS, FACS, FACE,
Santa Monica, CA
Shirin Haddady, MD, MPH, Boston, MA
Sun Lee, MD, Boston, MA
Joshua Klopper, MD, Denver, CO
Priya Mahajan, MD, Houston, TX
Maria Papaleontiou, MD, Ann Arbor, MI
Jason D. Prescott, MD PhD, Baltimore, MD
Marjorie Safran, MD, Worcester, MA
Anna M. Sawka, MD, Toronto, ON, Canada
Phillip Segal, MD, Toronto, ON, Canada
Vibhavasu Sharma, MD, Albany, NY
Ebru Sulanc, MD , Detroit, MI
Whitney Woodmansee, MD, Gainesville, FL

We welcome your feedback and suggestions. Let us know what you want to see in this publication.

Feedback & Suggestions

Published monthly and distributed free of charge to Friends of the ATA

Sign Up Here

Give Direct

IMA Outstanding Achievement Award